Terms: = Ovarian cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Diagnosis
31 results:
1. Imaging for local recurrence of breast cancer.
Schlaiss T; Bott L; Herbert SL; Bartmann C; Kiesel M; Salmen J; Sauer ST; Christner SA; Petritsch B; Grunz JP; Woeckel A; Löb S; Diessner J
J Cancer Res Clin Oncol; 2024 Apr; 150(4):200. PubMed ID: 38627285
[TBL] [Abstract] [Full Text] [Related]
2. ovarian Signet-ring Stromal Tumor: A Morphologic, Immunohistochemical, and Molecular Study of 7 Cases With Discussion of the Differential diagnosis.
Tchrakian N; Oliva E; Chong AS; Rivera-Polo B; Bennett JA; Nucci MR; Sah S; Schoolmeester JK; van der Griend RA; Foulkes WD; Clarke BA; Young RH; McCluggage WG
Am J Surg Pathol; 2022 Dec; 46(12):1599-1610. PubMed ID: 36040033
[TBL] [Abstract] [Full Text] [Related]
3. A 46-Year-Old Woman with Primary Infertility and a diagnosis of Microcystic Stromal Tumor of the Ovary Confirmed by Histology and Gene Sequencing: A Case Report and Review of the Literature.
Arafah MA; AlBreacan L; Akkour K; Alomar S
Am J Case Rep; 2021 Oct; 22():e933528. PubMed ID: 34667141
[TBL] [Abstract] [Full Text] [Related]
4. Corded and Hyalinized and Spindled Endometrioid Endometrial Carcinoma: A Clinicopathologic and Molecular Analysis of 9 Tumors Based on the TCGA Classifier.
Safdar NS; Thompson EF; Gilks CB; Isacson C; Bennett JA; Clarke B; Young RH; Oliva E
Am J Surg Pathol; 2021 Aug; 45(8):1038-1046. PubMed ID: 34115671
[TBL] [Abstract] [Full Text] [Related]
5. Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing".
D'Angelo E; Espinosa I; Cipriani V; Szafranska J; Barbareschi M; Prat J
Am J Surg Pathol; 2021 Jul; 45(7):988-996. PubMed ID: 34105519
[TBL] [Abstract] [Full Text] [Related]
6. Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline ovarian Tumors by Integrative Polygenic Analytics.
Chang CM; Li YF; Lin HC; Lu KH; Lin TW; Liu LC; Su KM; Chang CC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921111
[TBL] [Abstract] [Full Text] [Related]
7. FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
Weisman P; Park KJ; Xu J
Int J Gynecol Pathol; 2022 Mar; 41(2):126-131. PubMed ID: 33811207
[TBL] [Abstract] [Full Text] [Related]
8. Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome.
Hollis RL; Thomson JP; Stanley B; Churchman M; Meynert AM; Rye T; Bartos C; Iida Y; Croy I; Mackean M; Nussey F; Okamoto A; Semple CA; Gourley C; Herrington CS
Nat Commun; 2020 Oct; 11(1):4995. PubMed ID: 33020491
[TBL] [Abstract] [Full Text] [Related]
9. Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by ctnnb1 Mutations and Can Show Adverse Clinical Outcomes.
Ladwig NR; Umetsu SE; Zaloudek C; Rabban J; Garg K
Int J Gynecol Pathol; 2021 Mar; 40(2):103-115. PubMed ID: 32909971
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases.
Stewart CJR; Amanuel B; De Kock L; Apellaniz-Ruiz M; Carrello A; Giardina T; Grieu-Iacopetta F; Thomas MA; Foulkes WD
Pathology; 2020 Oct; 52(6):686-693. PubMed ID: 32782216
[TBL] [Abstract] [Full Text] [Related]
11. Identification of a Gene Panel for Endometrioid Endometrial cancer: a Possible Prognostic Value?
Malentacchi F; Turrini I; Sorbi F; Projetto E; Castiglione F; Vergoni F; Amunni G; Fambrini M; Petraglia F; Noci I; Pillozzi S
Reprod Sci; 2020 Feb; 27(2):592-598. PubMed ID: 32046431
[TBL] [Abstract] [Full Text] [Related]
12. Practical roles for molecular diagnostic testing in ovarian adult granulosa cell tumour, Sertoli-Leydig cell tumour, microcystic stromal tumour and their mimics.
Rabban JT; Karnezis AN; Devine WP
Histopathology; 2020 Jan; 76(1):11-24. PubMed ID: 31846522
[TBL] [Abstract] [Full Text] [Related]
13. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
Cuevas D; Valls J; Gatius S; Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X
Virchows Arch; 2019 May; 474(5):585-598. PubMed ID: 30710169
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathologic and Immunohistochemical Correlates of ctnnb1 Mutated Endometrial Endometrioid Carcinoma.
Costigan DC; Dong F; Nucci MR; Howitt BE
Int J Gynecol Pathol; 2020 Mar; 39(2):119-127. PubMed ID: 30702464
[TBL] [Abstract] [Full Text] [Related]
15. Bilateral Signet-ring Stromal Tumor of the Ovary: A Case Report With Next-generation Sequencing Analysis and FOXL2 Mutation Testing.
Chen PH; Hui P; Buza N
Int J Gynecol Pathol; 2020 Mar; 39(2):193-198. PubMed ID: 30676431
[TBL] [Abstract] [Full Text] [Related]
16. Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma.
Lazo de la Vega L; Samaha MC; Hu K; Bick NR; Siddiqui J; Hovelson DH; Liu CJ; Carter CS; Cho KR; Sciallis AP; Tomlins SA
Mol Cancer Res; 2019 Mar; 17(3):731-740. PubMed ID: 30610106
[TBL] [Abstract] [Full Text] [Related]
17. Excluding Lynch syndrome in a female patient with metachronous DNA mismatch repair deficient colon- and ovarian cancer.
Crobach S; Jansen AML; Ligtenberg MJL; Koopmans M; Nielsen M; Hes FJ; Wijnen JT; Dinjens WNM; van Wezel T; Morreau H
Fam Cancer; 2018 Jul; 17(3):415-420. PubMed ID: 29124495
[TBL] [Abstract] [Full Text] [Related]
18. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract] [Full Text] [Related]
19. Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.
Maru Y; Tanaka N; Ohira M; Itami M; Hippo Y; Nagase H
Gynecol Oncol; 2017 Feb; 144(2):377-383. PubMed ID: 27939411
[TBL] [Abstract] [Full Text] [Related]
20. Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.
Yuan W; Zhang Z; Dai B; Wei Q; Liu J; Liu Y; Liu Y; He L; Zhou D
Cancer; 2016 Jun; 122(11):1689-96. PubMed ID: 26998897
[TBL] [Abstract] [Full Text] [Related]
[Next]
